CHENGDU, China, Nov. 9 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical, Co., Inc., , a manufacturer and supplier of modernized traditional Chinese medicine (‘TCM’) based in Chengdu, China, today announced that management will hold a conference call to discuss its fiscal 2010 first quarter results at 10:30 a.m. ET on Friday, November 13, 2009. Financial results will be released prior to the market open on that day. A PowerPoint presentation which provides further details on the quarter and the recently announced Sichuan Jiangchuan Pharmaceutical Co. Ltd. joint venture will accompany management’s discussion and can be accessed via the webcast link.
A replay will be available through November 21, 2009 and can be accessed by dialing (800) 406-7325 (U.S.), (303) 590-3030 (Int’l), Pin Code 4182573.
Webcast Access Information
Access Link: http://www.talkpoint.com/viewer/starthere.asp?pres=128645
You will need to have the Windows Media Player on your desktop. For a free download: http://www.microsoft.com/windows/windowsmedia/en/download/default.asp .
About Tianyin Pharmaceuticals
Tianyin is a manufacturer and supplier of modernized traditional Chinese medicine in China. It was established in 1994 and acquired by the current management team in August 2003. It has a comprehensive product portfolio of 39 products, 22 of which are listed in the highly selective National Medicine Catalog of the National Medical Insurance program. Tianyin owns and operates three GMP manufacturing facilities and an R&D platform supported by leading Chinese academic institutions. The company has a pipeline of 17 pharmaceutical products pending approval. Tianyin has an extensive nationwide distribution network throughout China with a sales force of 720 salespeople. Tianyin is headquartered in Chengdu, Sichuan Province with three manufacturing facilities and a total of 1,365 employees. For more information about Tianyin, please visit http://www.tianyinpharma.com .
Safe Harbor Statement
The Statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company’s filings with the Securities and Exchange Commission.
CONTACT: Allen Tang, Ph.D., MBA, Assistant to the CEO of TPI, +86-158-
2122-5642, or Allen.y.tang@gmail.com; or Mr. Matthew Hayden of HC
International, +1-561-245-5155, or matt.hayden@hcinternational.net, for TPI
